金沙检测线路js95(中国)股份有限公司-Official website

You are about to leave Peijia Medical's official Chinese website.
You have just clicked on a link to another website. After clicking Continue, you may be taken to a website run by a third party. We are not responsible for the review and control of content outside Peijia Medical's official Chinese website, nor do we assume any responsibility for business transactions or matters conducted outside Peijia Medical's official Chinese website. The use of other websites is subject to the terms of use and privacy policies of those websites. Certain products or information found on other websites may not be approved for your region or country.
Cancel
Continue
媒体报道
公司新闻 创新速递 媒体报道
引力播:金沙检测线路js95经导管主动脉瓣置换术跃居国内“领头羊”
2026-07-15 17:16:26

2026年上半年,公司累计完成TAVR植入超2800例,同比增长约37%;得益于TaurusMax® 3D可调弯TAVR系统及主动脉瓣反流(AR)新产品TaurusTrio®的协同驱动,经股TAVR市场份额预计达约28%,跃居国内行业第一。



Top
XML 地图